EndoChoice® has announced that positive results of a pivotal comparison study of standard forward-viewing colonoscopy (SFV) and EndoChoice's Full Spectrum Endoscopy™ System (Fuse&trade were published in The Lancet Oncology. The study determined that standard forward-viewing colonoscopes missed 41% of adenomas (pre-cancerous polyps). The study showed that the Fuse™ Endoscopy System, equipped with multiple imagers that create a near-panoramic view, detected an additional 69% more pre-cancerous polyps than the standard forward-viewing colonoscopes.

More...